Medicare Part D coverage · ciprofloxacin · RxCUI 403908
ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension
Per the CMS 2026 Part D formulary file, ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension is covered by 4,004 Medicare Part D plans (79.3% of enrollable products), averaging Tier 2.7, with prior authorization required on 0% of covering formularies.
- 79.3%
- Plan coverage
- 4,004
- Plans covering
- T2.7
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension
Per the CMS 2026 Part D formulary file, ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension (RxNorm concept RXCUI 403908, generic name ciprofloxacin) appears on 277 distinct formulary files spanning 4,004 Medicare Part D plan offerings - 79.3% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.7.
Real-world access to ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 43% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,810 Part D beneficiaries filled ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension in 2023, with total plan-and-beneficiary spending of $396,416 and an average per-beneficiary annual cost of $219.01. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension today.
Coverage Details
- Formularies covering
- 277
- Plans covering
- 4,004
- Coverage rate
- 79.3%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 43% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,810
- Total spending
- $396,416
- Avg per beneficiary
- $219.01
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Wellpoint Medicare Advantage (HMO-POS) | Wellpoint West Virginia , Inc. | T1 | No | $0 | WV |
| Anthem Medicare Advantage 3 (HMO-POS) | Healthkeepers, Inc. | T1 | No | $0 | VA |
| Anthem Medicare Advantage 3 (HMO-POS) | Healthkeepers, Inc. | T1 | No | $0 | VA |
| Anthem Medicare Advantage 3 (HMO-POS) | Healthkeepers, Inc. | T1 | No | $0 | VA |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Tennessee, Inc. | T1 | No | $0 | TN |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Tennessee, Inc. | T1 | No | $0 | TN |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Tennessee, Inc. | T1 | No | $0 | TN |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Tennessee, Inc. | T1 | No | $0 | TN |
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | No | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | No | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | No | $0 | NY |
Show the next 30 plans
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | No | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | No | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | No | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| PruittHealth Premier D-SNP (HMO D-SNP) | Pruitthealth Premier, Inc. | T1 | No | $0 | GA |
| Simpra Advantage Dual Care (PPO D-SNP) | Simpra Advantage, Inc. | T1 | No | $0 | AL |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T1 | No | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | No | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | No | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| DualConnect (HMO D-SNP) | Santa Clara County Health Authority | T1 | No | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T1 | No | $0 | NY |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | No | $0 | NY |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension covered by Medicare Part D?
Yes, ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension is covered by 4,004 Medicare Part D plans (79.3% of all Part D formularies).
What tier is ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension on Medicare Part D plans?
ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension averages Tier 2.7 across Part D plans, ranging from Tier 1 to Tier 4.
Does ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension require prior authorization?
0% of Part D formularies require prior authorization for ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension. Step therapy: 0%. Quantity limits: 43%.
How much does Medicare spend on ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension?
In 2023, total Medicare Part D spending on ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension was $396,416, covering 1,810 beneficiaries. The average spend per beneficiary was $219.01.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog] T2.7
- aliskiren 150 MG Oral Tablet T2.7
- cyclosporine, modified 100 MG Oral Capsule T2.7
- Niacinamide insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp] T2.7
- tazarotene 1 MG/ML Topical Cream T2.7
- tenofovir disoproxil fumarate 300 MG Oral Tablet T2.7
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA